Aramark (ARMK) director adds shares via dividend equivalent rights

Rhea-AI Filing Summary

Aramark director reported a small increase in their holdings of the company’s common stock through dividend-related awards. On 12/17/2025, the reporting person acquired 35.42 shares of common stock, recorded at a price of $0 per share, reflecting that this was an award rather than an open-market purchase.

After this transaction, the director beneficially owned 16,731.732 shares of Aramark common stock in direct ownership. The filing explains that these additional shares represent dividend equivalent rights, which are credited in connection with Aramark’s quarterly dividend on deferred stock units and vest on the same schedule as the underlying awards.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wills Kevin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	35.42	$0.00	--

Holdings After Transaction: Common Stock — 16,731.732 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wills Kevin

(Last) (First) (Middle)

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		A		35.42(1)	A	$0	16,731.732	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aramark (ARMK) disclose in this Form 4?

The filing reports that a director of Aramark acquired 35.42 shares of common stock on 12/17/2025 through dividend equivalent rights credited on deferred stock units.

How many Aramark (ARMK) shares does the reporting person own after this transaction?

Following the reported transaction, the director beneficially owned 16,731.732 shares of Aramark common stock in direct ownership.

At what price were the Aramark (ARMK) shares acquired in this insider transaction?

The 35.42 shares were acquired at a stated price of $0 per share, indicating they were awarded as dividend equivalent rights rather than bought in the market.

What are the dividend equivalent rights mentioned in the Aramark (ARMK) Form 4?

The filing states that the transaction represents dividend equivalent rights credited in connection with Aramark’s quarterly dividend on deferred stock units, and these rights vest on the same schedules as the underlying awards.

What is the relationship of the reporting person to Aramark (ARMK)?

The reporting person is identified as a Director of Aramark, as indicated in the relationship section of the filing.

Was this Aramark (ARMK) insider transaction an open-market trade?

No. The 35.42 shares were acquired at $0 per share as dividend equivalent rights on deferred stock units, rather than through an open-market purchase.